HeartMate 3 LVAD Overview | 合法醫療器材資訊網

TheHeartMate​3™​LeftVentricularAssistDevice(LVAD)isamechanicalcirculatorysupportdevicedesignedforpatientswithadvancedheartfailure.

Our coding and reimbursement documents provide information about coverage, coding and payment, economic insights and supporting documentation for Abbott LVAD and mechanical circulatory support products.

On December 1, 2020, the Centers for Medicare and Medicaid Services (CMS) updated the final decision memo for National Coverage Determination (NCD 20.9.1) for Ventricular Assist Devices.

CMS removed the pre-implant designations (bridge-to-transplant and destination therapy) in favor of central clinical criteria for qualification of VADs for the purpose of coverage and payment effective for dates of services on and after December 1, 2020.

To access the final decision memo and the analysis in its entirety please go to cms.gov[1].